What is DHEA E4M (Slow Release) Capsule 25mg? 

This oral HRT formulation contains Dehydroepiandrosterone (DHEA) at 25mg in an E4M (Ethylcellulose) slow-release matrix, designed for hormone replacement therapy research and clinical use. Supplied as a 90-day capsule supply, it is formulated to study extended-release precursor hormone delivery, sustained steroidogenic activity, and time-dependent hormonal conversion kinetics under controlled clinical conditions.

Mechanism of Action The E4M slow-release matrix gradually dissolves the DHEA compound, enabling controlled and time-dependent absorption into systemic circulation. This sustained-release mechanism ensures a consistent plasma concentration profile, reducing hormonal fluctuations while supporting steady enzymatic conversion of DHEA into androgens and estrogens via peripheral steroidogenic pathways.

The Science

• Study extended-release DHEA delivery and absorption kinetics
• Evaluate time-dependent steroidogenic conversion and hormonal plasma levels
• Assess sustained androgenic and estrogenic receptor activation patterns
• Analyze E4M matrix dissolution rates and compound bioavailability
• Conduct reproducible slow-release in vitro and clinical pharmacokinetic studies

Purity & Quality

• ≥99% purity verified via HPLC
• Certificate of Analysis included

Storage: Store at room temperature in a cool, dry place

Intended Use This compound is intended strictly for use by trained professionals. Our compounds are not “research only” and require an Rx, which we provide through our tele-health and/or a HIPAA Compliant Intake Form reviewed by a Medical Professional.

Note BodyBossRx works with various top pharmacies to ensure you will always have your medication efficiently; therefore, labeling may differ.

Terms of Sale These are sterile compounds. All sales are final. If you are not a professional, the Purchaser (YOU) assumes full responsibility to be guided on dosing, administering, etc. by a medical professional.